


Ask a doctor about a prescription for MIXTARD 30 100 IU/ml INJECTABLE SUSPENSION IN VIAL
Package Leaflet: Information for the User
Mixtard 30 100UI/ml(International Units/ml) injectable suspension in a vial
human insulin
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Mixtard is a fast-acting and long-acting human insulin.
Mixtard is used to reduce high blood sugar levels in patients with diabetes mellitus (diabetes).
Diabetes is a disease in which your body does not produce enough insulin to control your blood sugar levels. Treatment with Mixtard helps to prevent complications of diabetes.
Mixtard starts to reduce your blood sugar level about 30 minutes after injection and the effect lasts for approximately 24 hours.
Do not use Mixtard
If any of these conditions apply to you, do not use Mixtard. Talk to your doctor, pharmacist, or nurse.
Before using Mixtard
Warnings and precautions
Certain conditions and activities may affect your insulin needs. Consult your doctor:
Changes in the skin at the injection site
You should rotate the injection site to help avoid changes in the fatty tissue under the skin, such as thickening of the skin, shrinking of the skin or lumps under the skin. Insulin may not work well if you inject into a lumpy, shrunk or thickened area (see section 3). Inform your doctor if you notice any changes at the injection site. Inform your doctor if you are currently injecting into these affected areas before you start injecting into a different area. Your doctor may tell you to check your blood sugar levels more closely and to adjust your insulin dose or other antidiabetic medications.
Other medicines and Mixtard
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines.
Certain medicines affect your blood sugar level, and this may mean you need to adjust your insulin dose. The following are the most common medicines that may affect your insulin treatment.
Your blood sugar level may decrease (hypoglycaemia) if you take:
Your blood sugar level may increase (hyperglycaemia) if you take:
Octreotide and lanreotide (used to treat acromegaly, a rare hormonal disorder that usually occurs in middle-aged adults, caused by an excess production of growth hormone in the pituitary gland) may increase or decrease your blood sugar level.
Beta-blockers (used to treat high blood pressure) may weaken or completely suppress the first warning symptoms that help you recognize a low blood sugar level.
Pioglitazone (tablets used to treat type 2 diabetes)
Some patients with long-standing type 2 diabetes and a history of heart disease or stroke who were treated with pioglitazone and insulin developed heart failure. Inform your doctor as soon as possible if you have signs of heart failure such as unusual shortness of breath, rapid weight gain, or localized swelling (oedema).
If you have taken any of the medicines listed above, inform your doctor, pharmacist, or nurse.
Using Mixtard with alcohol
? If you drink alcohol, your insulin needs may change, as your blood sugar level may increase or decrease. You are advised to keep a close check on this.
Pregnancy and breastfeeding
? If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine. Mixtard can be used during pregnancy. You may need to adjust your insulin dose during pregnancy and after delivery. Keeping a close check on your diabetes, especially to prevent hypoglycaemia, is important for the health of your baby.
? There are no restrictions on the use of Mixtard during breastfeeding.
Ask your doctor, pharmacist, or nurse for advice before taking this medicine during pregnancy or breastfeeding.
Driving and using machines
? Ask your doctor whether you can drive a vehicle or use machines:
If your blood sugar is too high or too low, it may affect your concentration and ability to react, which could put you or others in danger.
Mixtard contains sodium
Mixtard contains less than 1 mmol of sodium (23 mg) per dose; this is essentially “sodium-free”.
Dose and when to use the insulin
Follow the instructions for administration of this medicine and the dose given by your doctor. If you are not sure, ask your doctor, pharmacist, or nurse again.
Eat a meal or snack containing carbohydrates within 30 minutes of the injection to avoid a drop in blood sugar level.
Do not change your insulin unless your doctor tells you to. If your doctor switches you from one type or brand of insulin to another, you may need to adjust your dose.
Use in children and adolescents
Mixtard can be used in children and adolescents.
Use in special patient groups
If you have kidney or liver problems or if you are over 65 years old, you should check your blood sugar levels more often and talk to your doctor about possible changes in your insulin dose.
How and where to inject the insulin
Mixtard is administered by injection under the skin (subcutaneous administration). It should never be injected directly into a vein (intravenous injection) or muscle (intramuscular injection).
For each injection, change the injection site within the area of skin you use. This may reduce the risk of developing lumps or hollows in the skin, see section 4. The best areas for injection are: the front of the waist (abdomen), the buttocks, the front of the thighs or the upper arm. The effect of the insulin will be faster if you inject into the abdomen. You should measure your blood sugar level regularly.
How to use Mixtard
Mixtard vials are to be used with insulin syringes graduated to match the dose of insulin to be injected.
How to inject Mixtard
If you use more insulin than you should
If you use too much insulin, your blood sugar level may become too low (hypoglycaemia). See Summary of serious and very common side effects in section 4.
If you forget to use your insulin
If you forget to use your insulin, your blood sugar level may become too high (hyperglycaemia). See Effects of diabetes in section 4.
If you stop using your insulin
Do not stop using your insulin without talking to your doctor first. Stopping your insulin may lead to very high blood sugar levels (severe hyperglycaemia) and ketoacidosis. See Effects of diabetes in section 4.
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Summary of Serious and Very Frequent Adverse Effects
Low Blood Sugar Level (Hypoglycemia)is a very frequent adverse effect. It can affect more than 1 in 10 people.
Blood sugar levels can drop if:
Signs of a drop in blood sugar level: cold sweat, cold and pale skin, headache, rapid heartbeat, feeling of discomfort, excessive appetite, temporary visual disturbances, drowsiness, unusual fatigue and weakness, nervousness or tremors, anxiety, confusion, difficulty concentrating.
A severe drop in blood sugar level can lead to loss of consciousness. If left untreated, it can cause brain damage (temporary or permanent) and even death. You can regain consciousness more quickly if someone who knows how to do it administers a glucagon injection to you. If you are given glucagon, you should also take glucose or a sugary product as soon as you regain consciousness. If you do not respond to glucagon treatment, you will need to receive hospital treatment.
What to do if you suffer from low blood sugar:
? If you suffer from low blood sugar, take glucose tablets or another product with a high sugar content (e.g., candies, cookies, fruit juice). If possible, measure your blood sugar level and rest. Always carry glucose tablets or sugary products with you, just in case.
? When the symptoms of low blood sugar have disappeared or when your blood sugar level has stabilized, continue with your usual insulin treatment.
? If your blood sugar level is so low that you faint, if you have needed a glucagon injection, or if you have had many episodes of low blood sugar, talk to your doctor. You may need to adjust the dose or frequency of insulin administration, your eating habits, or exercise.
Inform relevant people that you have diabetes and what the consequences may be, such as the risk of fainting (loss of consciousness) due to low blood sugar. Let them know that if you faint, they should turn you onto your side and seek immediate medical attention. They should not give you food or drinks, as you may choke.
Severe Allergic Reactionto Mixtard or one of its components (called a systemic allergic reaction) is a very rare but potentially life-threatening adverse effect. It can affect up to 1 in 10,000 people.
Consult your doctor immediately:
? If you notice any of these symptoms, seek medical help immediately.
Changes in the Skin at the Injection Site: If you inject insulin in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy) (can affect up to 1 in 100 people). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis; the frequency of this is unknown). Insulin may not work very well if injected into a lumpy, shrunken, or thickened area. Change the injection site to help avoid these skin changes.
List of Other Adverse Effects
Uncommon Adverse Effects
Can affect up to 1 in 100 people.
Allergy Symptoms: local allergic reactions (pain, redness, hives, inflammation, bruising, swelling, and itching) can occur at the injection site. They usually disappear a few weeks after starting insulin therapy. If they do not disappear or spread throughout the body, you should consult your doctor immediately. See also the severe allergic reactions mentioned above.
Diabetic Retinopathy(eye disease related to diabetes that can cause vision loss): if you have diabetic retinopathy and your blood sugar level improves very quickly, the retinopathy can worsen. In this case, you should consult your doctor.
Joint Inflammation: when starting insulin therapy, fluid accumulation can cause inflammation of the ankles and other joints. This effect usually disappears quickly. If it does not, consult your doctor.
Painful Neuropathy(pain due to nerve damage): if your blood sugar level improves very quickly, you may experience pain related to the nerves. This is known as acute painful neuropathy and is usually transient.
Very Rare Adverse Effects
Can affect up to 1 in 10,000 people.
Vision Problems: when starting insulin therapy, your vision may be affected, but it is usually temporary.
Reporting Adverse Effects
If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are possible adverse effects not listed in this leaflet. You can also report them directly through the national reporting system included in Annex V. By reporting adverse effects, you can help provide more information on the safety of this medicine.
Effects Derived from Diabetes
High Blood Sugar Level (Hyperglycemia)
You may experience high blood sugar if:
Warning signs of high blood sugar:
The warning signs appear gradually and include frequent urination, thirst, loss of appetite, feeling of discomfort (nausea or vomiting), drowsiness or fatigue, dry and reddened skin, dry mouth, and fruity breath (acetone).
What to do in case of high blood sugar:
? If you experience any of the above symptoms: check your blood sugar level and the presence of ketones in your urine if possible, and then consult your doctor immediately.
? They can be symptoms of a very serious condition called diabetic ketoacidosis (acid buildup in the blood due to the body breaking down fat instead of sugar). If left untreated, it can lead to diabetic coma and even death.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the label and carton after EXP. The expiration date is the last day of the month indicated.
Before Opening: store in a refrigerator (between 2°C and 8°C). Keep away from the cooling element. Do not freeze.
During Use or as a Spare: do not refrigerate or freeze. It can be carried and stored at room temperature (below 25°C) for up to 6 weeks.
Always keep the vial in the outer carton when not in use to protect it from light.
Discard the needle and syringe after each injection.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Mixtard 30 Composition
Product Appearance and Package Contents
Mixtard is presented as an injectable suspension. After resuspension, the liquid should have a uniformly white and cloudy appearance.
Package sizes of 1 or 5 vials of 10 ml or a multipack of 5 packs of 1 vial of 10 ml. Not all pack sizes may be marketed.
The suspension is aqueous, white, and cloudy in appearance.
Marketing Authorization Holder
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd, Denmark
Manufacturer
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd, Denmark
Novo Nordisk Production SAS
45, Avenue d'Orléans
F-28000 Chartres, France
Date of Last Revision of this Leaflet
Other Sources of Information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MIXTARD 30 100 IU/ml INJECTABLE SUSPENSION IN VIAL – subject to medical assessment and local rules.